Dynamic Alterations in DNA Methylation of CD4⁺ T Cells and Macrophages in a Murine Model of Tuberculous Pleural Infection Induced by BCG Vaccination

Abstract

Tuberculous pleural effusion (TPE) is a prevalent form of extrapulmonary tuberculosis, and immune abnormalities play a crucial role in promoting its development. However, the dynamic changes and regulatory characteristics of immune cells during TPE progression remain incompletely understood. This study analyzed DNA methylation and transcriptome data from macrophages and CD4⁺ T cells from pleural lavage fluid of BCG-induced tuberculous pleurisy mouse models at specific time points (Days 0, 1, 7, and 14). The results revealed substantial alterations in DNA methylation patterns associated with inflammatory factors and interferon genes. Notably, macrophages exhibited the most pronounced differences in DNA methylation profiles on Day 1, while CD4⁺ T cells demonstrated gradual changes over time. The investigation further indicated that DNA methylation primarily regulated the differentiation of Th1, Th17, and Th22 cells but not Th9 cells. Additionally, single-cell RNA sequencing analysis revealed an increasing expression of C1q during infection, which was regulated by DNA methylation. Importantly, C1q⁺ and C1q⁻ macrophages demonstrated distinct roles in modulating immune responses during infection. This research provides valuable insights into the DNA methylation profile of immune cells during Mycobacterium bovis infection–induced pleurisy in a mouse model, enhancing our understanding of the upstream regulatory mechanisms underlying immune response development in TPE.

Keywords

BCG vaccination / C1q / CD4⁺ T cells / DNA methylation / Macrophages / tuberculous pleural infection

References

[1] Z. H. Tong and H. Z. Shi, “Subpopulations of Helper T Lymphocytes in Tuberculous Pleurisy,” Tuberculosis 93, no. 3 (2013): 279-284.

[2] E. Vakil, N. Taghizadeh, and A. Tremblay, “The Global Burden of Pleural Diseases,” Seminars in Respiratory and Critical Care Medicine 44, no. 4 (2023): 417-425.

[3] O. Menezes-de-Lima-Junior, E. Werneck-Barroso, R. S. Cordeiro, and M. G. Henriques, “Effects of Inhibitors of Inflammatory Mediators and Cytokines on Eosinophil and Neutrophil Accumulation Induced by Mycobacterium bovis bacillus Calmette-Guerin in Mouse Pleurisy,” Journal of Leukocyte Biology 62, no. 6 (1997): 778-785.

[4] M. C. Souza, C. Penido, M. F. Costa, and M. G. Henriques, “Mechanisms of T-Lymphocyte Accumulation During Experimental Pleural Infection Induced by Mycobacterium bovis BCG,” Infection and Immunity 76, no. 12 (2008): 5686-5693.

[5] K. D. Mayer-Barber and D. L. Barber, “Innate and Adaptive Cellular Immune Responses to Mycobacterium tuberculosis Infection,” Cold Spring Harbor Perspectives in Medicine 5, no. 12 (2015): a018424.

[6] J. L. Flynn and J. Chan, “Immune Cell Interactions in Tuberculosis,” Cell 185, no. 25 (2022): 4682-4702.

[7] J. Murphy, R. Summer, A. A. Wilson, D. N. Kotton, and A. Fine, “The Prolonged Life-Span of Alveolar Macrophages,” American Journal of Respiratory Cell and Molecular Biology 38, no. 4 (2008): 380-385.

[8] M. Guilliams, I. De Kleer, S. Henri, et al., “Alveolar Macrophages Develop From Fetal Monocytes That Differentiate Into Long-Lived Cells in the First Week of Life via GM-CSF,” Journal of Experimental Medicine 210, no. 10 (2013): 1977-1992.

[9] P. Chandra, S. J. Grigsby, and J. A. Philips, “Immune Evasion and Provocation by Mycobacterium tuberculosis,” Nature Reviews Microbiology 20, no. 12 (2022): 750-766.

[10] K. D. Kauffman, S. Sakai, N. E. Lora, et al., “PD-1 Blockade Exacerbates Mycobacterium tuberculosis Infection in Rhesus Macaques,” Science Immunology 6, no. 55 (2021): eabf3861.

[11] D. L. Barber, S. Sakai, R. R. Kudchadkar, et al., “Tuberculosis Following PD-1 Blockade for Cancer Immunotherapy,” Science Translational Medicine 11, no. 475 (2019): eaat2702.

[12] I. M. Orme, R. T. Robinson, and A. M. Cooper, “The Balance Between Protective and Pathogenic Immune Responses in the TB-Infected Lung,” Nature Immunology 16, no. 1 (2015): 57-63.

[13] P. A. Darrah, J. J. Zeppa, C. Wang, et al., “Airway T Cells Are a Correlate of i.v. Bacille Calmette-Guerin-Mediated Protection Against Tuberculosis in Rhesus Macaques,” Cell Host & Microbe 31, no. 6 (2023): 962-977.e968.

[14] R. Basu Roy, E. Whittaker, J. A. Seddon, and B. Kampmann, “Tuberculosis Susceptibility and Protection in Children,” Lancet Infectious Diseases 19, no. 3 (2019): e96-e108.

[15] L. Martinez, O. Cords, Q. Liu, et al., “Infant BCG Vaccination and Risk of Pulmonary and Extrapulmonary Tuberculosis Throughout the Life Course: A Systematic Review and Individual Participant Data Meta-Analysis,” Lancet Global Health 10, no. 9 (2022): e1307-e1316.

[16] A. Nishiyama and M. Nakanishi, “Navigating the DNA Methylation Landscape of Cancer,” Trends in Genetics 37, no. 11 (2021): 1012-1027.

[17] A. R. DiNardo, K. Rajapakshe, T. Nishiguchi, et al., “DNA Hypermethylation During Tuberculosis Dampens Host Immune Responsiveness,” Journal of Clinical Investigation 130, no. 6 (2020): 3113-3123.

[18] M. Looney, R. Lorenc, M. K. Halushka, and P. C. Karakousis, “Key Macrophage Responses to Infection With Mycobacterium Tuberculosis Are Co-Regulated by microRNAs and DNA Methylation,” Frontiers in Immunology 12 (2021): 685237.

[19] A. Singhania, P. Dubelko, R. Kuan, et al., “CD4+CCR6+ T Cells Dominate the BCG-Induced Transcriptional Signature,” eBioMedicine 74 (2021): 103746.

[20] Y. Cai, Q. Yang, Y. Tang, et al., “Increased Complement C1q Level Marks Active Disease in Human Tuberculosis,” PLoS ONE 9, no. 3 (2014): e92340.

[21] R. Lubbers, J. S. Sutherland, D. Goletti, et al., “Complement Component C1q as Serum Biomarker to Detect Active Tuberculosis,” Frontiers in Immunology 9 (2018): 2427.

[22] X. Yang, J. Yan, Y. Xue, et al., “Single-Cell Profiling Reveals Distinct Immune Response Landscapes in Tuberculous Pleural Effusion and Non-TPE,” Frontiers in Immunology 14 (2023): 1191357.

[23] M. P. Berry, C. M. Graham, F. W. McNab, et al., “An Interferon-Inducible Neutrophil-Driven Blood Transcriptional Signature in Human Tuberculosis,” Nature 466, no. 7309 (2010): 973-977.

[24] X. Qiao, M. M. Shao, F. S. Yi, and H. Z. Shi, “Complement Component C1q as an Emerging Biomarker for the Diagnosis of Tuberculous Pleural Effusion,” Frontiers in Microbiology 12 (2021): 765471.

[25] H. Bosshart and M. Heinzelmann, “THP-1 Cells as a Model for Human Monocytes,” Annals of Translational Medicine 4, no. 21 (2016): 438.

[26] D. Kumar, L. Nath, M. A. Kamal, et al., “Genome-Wide Analysis of the Host Intracellular Network That Regulates Survival of Mycobacterium Tuberculosis,” Cell 140, no. 5 (2010): 731-743.

[27] I. Pehrson, S. Sayyab, J. Das, et al., “The Spectrum of Tuberculosis Described as Differential DNA Methylation Patterns in Alveolar Macrophages and Alveolar T Cells,” Clinical Epigenetics 14, no. 1 (2022): 175.

[28] L. Chavez-Galan, D. Vesin, N. Segueni, et al., “Tumor Necrosis Factor and Its Receptors Are Crucial to Control Mycobacterium bovis Bacillus Calmette-Guerin Pleural Infection in a Murine Model,” American Journal of Pathology 186, no. 9 (2016): 2364-2377.

[29] S. B. Cohen, B. H. Gern, J. L. Delahaye, et al., “Alveolar Macrophages Provide an Early Mycobacterium Tuberculosis Niche and Initiate Dissemination,” Cell Host & Microbe 24, no. 3 (2018): 439-446.e434.

[30] G. Hu and J. W. Christman, “Editorial: Alveolar Macrophages in Lung Inflammation and Resolution,” Frontiers in Immunology 10 (2019): 2275.

[31] T. Hussell and T. J. Bell, “Alveolar Macrophages: Plasticity in a Tissue-Specific Context,” Nature Reviews Immunology 14, no. 2 (2014): 81-93.

[32] P. A. Darrah, J. J. Zeppa, P. Maiello, et al., “Prevention of Tuberculosis in Macaques After Intravenous BCG Immunization,” Nature 577, no. 7788 (2020): 95-102.

[33] A. M. Cooper, “Cell-Mediated Immune Responses in Tuberculosis,” Annual Review of Immunology 27 (2009): 393-422.

[34] E. Kaufmann, J. Sanz, J. L. Dunn, et al., “BCG Educates Hematopoietic Stem Cells to Generate Protective Innate Immunity Against Tuberculosis,” Cell 172, no. 1-2 (2018): 176-190.e119.

[35] L. Li, D. Qiao, X. Fu, S. Lao, X. Zhang, and C. Wu, “Identification of M. tuberculosis-specific Th1 Cells Expressing CD69 Generated In Vivo in Pleural Fluid Cells From Patients With Tuberculous Pleurisy,” PLoS ONE 6, no. 8 (2011): e23700.

[36] N. Dalbeth and Y. C. Lee, “Lymphocytes in Pleural Disease,” Current Opinion in Pulmonary Medicine 11, no. 4 (2005): 334-339.

[37] K. Dijkman, R. Lubbers, N. V. Borggreven, et al., “Systemic and Pulmonary C1q as Biomarker of Progressive Disease in Experimental Non-Human Primate Tuberculosis,” Scientific Reports 10, no. 1 (2020): 6290.

[38] G. Chen, C. S. Tan, B. K. Teh, and J. Lu, “Molecular Mechanisms for Synchronized Transcription of Three Complement C1q Subunit Genes in Dendritic Cells and Macrophages,” Journal of Biological Chemistry 286, no. 40 (2011): 34941-34950.

[39] R. S. Scotland, M. J. Stables, S. Madalli, P. Watson, and D. W. Gilroy, “Sex Differences in Resident Immune Cell Phenotype Underlie More Efficient Acute Inflammatory Responses in Female Mice,” Blood 118, no. 22 (2011): 5918-5927.

RIGHTS & PERMISSIONS

2025 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.